Advertisement

24-hour Recoveries Outnumber Daily New COVID Cases for Fifth Time in last 6 Days

Follow The Hawk on Google News+ Follow

Advertisement


Decline of 55,344 in Active Caseload in the last 24 hours

India's Cumulative Vaccination Coverage exceeds 18.22 Crore

Advertisement

More than 48 lakh beneficiaries of age group 18-44 Vaccinated, so far

Also readFSSAI to initiate action against Bisleri over unsafe water sample

New Delhi (The Hawk): India's cumulative recoveries have reached 2,07,95,335 today. The National Recovery Rate is 84.25%.

3,62,437 recoveries were registered in the last 24 hours. It outnumbers India's Daily New COVID cases for the fifth time in the last six days.

Advertisement

Ten states account for 70.94% of the new recoveries.

Also read'Fatty liver-free campaign' in Ranchi from Nov 23, MoS Sanjay Seth to take lead
24-hour Recoveries Outnumber Daily New COVID Cases for Fifth Time in last 6 Days

On the other front, India's total Active Caseload has decreased to 36,18,458 today. It now comprises 14.66% of the country's total Positive Cases.

A net decline of 55,344 cases is recorded in the active caseload in the last 24 hours.

10 States cumulatively account for 74.69% of India's total Active Cases.

24-hour Recoveries Outnumber Daily New COVID Cases for Fifth Time in last 6 Days

The graph below highlights the change in active cases for states in the last 24 hours.

A declining trend in positivity rate is also observed which stood now at 16.98% as shown below.

The cumulative number of COVID-19 vaccine doses administered in the country has exceeded 18.22 Cr today under the Phase-3 of the nationwide Vaccination Drive.

A total of 18,22,20,164 vaccine doses have been administered through 26,55,003sessions, as per the provisional report till 7 am today. These include 96,42,278 HCWs who have taken the 1st dose and 66,41,047 HCWs who have taken the 2nddose, 1,44,25,044 FLWs (1stdose), 81,86,568 FLWs (2nddose), 48,25,799 beneficiaries under 18-44 age group (1stdose), 5,71,61,076 (1stdose) and 90,66,862 (2nd dose) beneficiaries aged 45 to 60 years. 5,44,69,599 1stdose beneficiaries and 1,78,01,891 2nd dose beneficiaries of more than 60 years old.

Get The Hawk first on Google

Add The Hawk as a preferred source and Google shows you more of our stories in Top Stories. Follow us on Google News too.

Share this story

Advertisement

India eyes space-based drug development as scientists, startups explore microgravity researchRead next →India eyes space-based drug development as scientists, startups explore microgravity researchHealth · 22 Nov 2026, 03:08 PM IST